Literature DB >> 17610507

Helicobacter pylori infection in hepatic encephalopathy: Relationship to plasma endotoxins and blood ammonia.

Hassan Abdel-Hady1, Ali Zaki, Gamal Badra, Mahmoud Lotfy, Carlo Selmi, Alessia Giorgini, Mohamed El-Sayed, Reda Badr.   

Abstract

BACKGROUND/AIM: Hepatic encephalopathy (HE) is frequently observed in patients with advanced liver disease and manifests a wide variety of neuropsychiatric signs and symptoms. Ammonia toxicity and bacterial endotoxins have been suggested as key determinants of HE onset whereas a role for Helicobacter pylori infection has not been established. We investigated the correlation between H. pylori infection and HE severity (evaluated through functional tests) in 60 outpatients with established liver cirrhosis and 20 non-cirrhotic controls.
METHODS: Fasting arterial blood ammonia, plasma endotoxins, and H. pylori infection status were investigated in all subjects.
RESULTS: H. pylori infection was documented in 35/60 (58%) patients and in 6/20 (30%) controls (P = 0.039). Significant differences were observed between patients with and withoutHE for age, presence of ascites, fasting arterial blood ammonia, plasma endotoxin, and H. pylori infection. Further, a significant increase in fasting arterial blood ammonia and plasma endotoxin was associated with H. pylori infection in cirrhotic patients. Last, medical treatment of H. pylori infection led to a significant decrease in HE severity and fasting arterial blood ammonia levels.
CONCLUSION: In conclusion, we submit that H. pylori infection might, in fact, play a role in increasing the circulating levels of ammonia and endotoxins in cirrhotic patients, thus facilitating the onset of HE.

Entities:  

Year:  2007        PMID: 17610507     DOI: 10.1111/j.1872-034X.2007.00146.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  9 in total

1.  The association of Helicobacter pylori with choroidal and retinal nerve fiber layer thickness.

Authors:  Mehmet Erol Can; Fatma Efe Kaplan; Mehmet Murat Uzel; Hasan Kiziltoprak; Mustafa Cagri Ergun; Mustafa Koc; Gülcin Simsek
Journal:  Int Ophthalmol       Date:  2017-08-05       Impact factor: 2.031

2.  Helicobacter pylori and Hepatitis C Virus Coinfection in Egyptian Patients.

Authors:  Samir El-Masry; Mohamed El-Shahat; Gamal Badra; Mohamed F Aboel-Nour; Mahmoud Lotfy
Journal:  J Glob Infect Dis       Date:  2010-01

3.  Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients.

Authors:  Shu-Jie Chen; Liang-Jing Wang; Qin Zhu; Jian-Ting Cai; Tao Chen; Jian-Min Si
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

Review 4.  Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases.

Authors:  Elizabeth Ma Rabelo-Gonçalves; Bruna M Roesler; José Mr Zeitune
Journal:  World J Hepatol       Date:  2015-12-28

Review 5.  Can Helicobacter pylori infection influence human reproduction?

Authors:  Elena Moretti; Natale Figura; Giulia Collodel; Antonio Ponzetto
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 6.  Helicobacter pylori infection: new pathogenetic and clinical aspects.

Authors:  Krisztina Hagymási; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

Review 7.  Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease.

Authors:  Meng Li; Zhe Shen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

Review 8.  Host pathogen interactions in Helicobacter pylori related gastric cancer.

Authors:  Magdalena Chmiela; Zuzanna Karwowska; Weronika Gonciarz; Bujana Allushi; Paweł Stączek
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

9.  Association of Helicobacter pylori with elevated blood ammonia levels in cirrhotic patients: a meta-analysis.

Authors:  Hai-Xing Jiang; Shan-Yu Qin; Zhi-gang Min; Ming-Zhi Xie; Tao Lin; Bang-Li Hu; Xiao-Yun Guo
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.